{"id":"https://openalex.org/W4391090971","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.598","title":"Prognostic value of O6-methylguanine-DNA methyltransferase (MGMT) status in pancreatic neuroendrocrine tumors with capecitabine and temozolomide (CAPTEM).","display_name":"Prognostic value of O6-methylguanine-DNA methyltransferase (MGMT) status in pancreatic neuroendrocrine tumors with capecitabine and temozolomide (CAPTEM).","publication_year":2024,"publication_date":"2024-01-20","ids":{"openalex":"https://openalex.org/W4391090971","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.598"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.3_suppl.598","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.598","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.3_suppl.598","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041023560","display_name":"E. Ter\u00e1n Brage","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo Ter\u00e1n Brage","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019047604","display_name":"Jorge Feito","orcid":"https://orcid.org/0000-0003-2667-5332","observed_orcids":["https://orcid.org/0000-0003-2667-5332"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge Feito P\u00e9rez","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074723295","display_name":"M Navarro","orcid":"https://orcid.org/0000-0003-3502-0805","observed_orcids":["https://orcid.org/0000-0003-3502-0805"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Miguel Navarro Mart\u00edn","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022658462","display_name":"Roberto Andr\u00e9s Escala Cornejo","orcid":"https://orcid.org/0000-0002-6145-7683","observed_orcids":["https://orcid.org/0000-0002-6145-7683"]},"institutions":[{"id":"https://openalex.org/I4400600928","display_name":"Sociedad de Lucha Contra el C\u00e1ncer del Ecuador","ror":"https://ror.org/02wm3rq58","country_code":"EC","type":"healthcare","lineage":["https://openalex.org/I4400600928"]}],"countries":["EC"],"is_corresponding":false,"raw_author_name":"Roberto Andr\u00e9s Escala Cornejo","raw_affiliation_strings":["Instituto Oncologico Nacional Solca-Guayaquil, Guayaquil, Ecuador"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Oncologico Nacional Solca-Guayaquil, Guayaquil, Ecuador","institution_ids":["https://openalex.org/I4400600928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014013713","display_name":"Mar\u00eda del Mar Abad\u2010Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Mar Abad Hern\u00e1ndez","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065497666","display_name":"Sof\u00eda del Carmen","orcid":"https://orcid.org/0000-0001-9565-2009","observed_orcids":["https://orcid.org/0000-0001-9565-2009"]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sof\u00eda Del Carmen","raw_affiliation_strings":["Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Cantabria, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Cantabria, Spain","institution_ids":["https://openalex.org/I4210099858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012761803","display_name":"\u00c1lvaro L\u00f3pez Guti\u00e9rrez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"\u00c1lvaro L\u00f3pez Guti\u00e9rrez","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087105526","display_name":"B. Cigarral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bel\u00e9n Cigarral Garc\u00eda","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069925163","display_name":"Rosario Vidal Tocino","orcid":"https://orcid.org/0000-0002-0588-2001","observed_orcids":["https://orcid.org/0000-0002-0588-2001"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rosario Vidal Tocino","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028251370","display_name":"Rebeca Lozano Mejorada","orcid":"https://orcid.org/0000-0001-9567-6385","observed_orcids":["https://orcid.org/0000-0001-9567-6385"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rebeca Lozano","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056916329","display_name":"Emilio Fonseca S\u00e1nchez","orcid":"https://orcid.org/0000-0001-8157-9824","observed_orcids":["https://orcid.org/0000-0001-8157-9824"]},"institutions":[{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Emilio Fonseca S\u00e1nchez","raw_affiliation_strings":["Hospital Universitario de Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I4210099034"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"3_suppl","first_page":"598","last_page":"598"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.968999981880188},{"id":"https://openalex.org/keywords/mgmt","display_name":"MGMT","score":0.7409999966621399},{"id":"https://openalex.org/keywords/o6-methylguanine-dna-methyltransferase","display_name":"O6-methylguanine-DNA methyltransferase","score":0.9639999866485596},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9020000100135803},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":1.0},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9110000133514404},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8880000114440918},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8370000123977661},{"id":"https://openalex.org/keywords/pyrosequencing","display_name":"pyrosequencing","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8266135454177856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7363341450691223},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.7026286721229553},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6620097160339355},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.6182289123535156},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.5877540707588196},{"id":"https://openalex.org/C2779527866","wikidata":"https://www.wikidata.org/wiki/Q21118735","display_name":"O-6-methylguanine-DNA methyltransferase","level":5,"score":0.5688237547874451},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5509291887283325},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.5338063836097717},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4355296492576599},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.4301433861255646},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3806600272655487},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3146820068359375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24440860748291016},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1381022036075592},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10276326537132263},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.08600419759750366},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.3_suppl.598","doi":"https://doi.org/10.1200/jco.2024.42.3_suppl.598","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.3_suppl.598","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4382806701","https://openalex.org/W4406583183","https://openalex.org/W2912765980","https://openalex.org/W2600375888","https://openalex.org/W2017283276","https://openalex.org/W2033172867","https://openalex.org/W2466852244","https://openalex.org/W2512663019","https://openalex.org/W4282984041","https://openalex.org/W2913061980"],"abstract_inverted_index":{"598":[0],"Background:":[1],"Loss":[2],"of":[3,12,34,253],"MGMT":[4,35,75,93,115,143,150,244,263],"expression":[5],"has":[6],"been":[7],"suggested":[8],"as":[9,273],"a":[10,156,237,274],"predictor":[11],"response":[13,158],"to":[14,29,66,92,288],"alkylating":[15,282],"agents":[16],"in":[17,44,55,119,125,135,140,160,188,229,278,293],"pancreatic":[18],"neuroendocrine":[19],"tumors":[20],"(pNET),":[21],"however,":[22],"its":[23,290],"determination":[24],"is":[25,286],"controversial.":[26],"We":[27,80,154],"aim":[28],"analyze":[30],"the":[31,247,250],"prognostic":[32,276,291],"value":[33,292],"status":[36],"assessed":[37],"by":[38,72,78,129,245,266,271],"immunohistochemistry":[39],"(IHC)":[40],"or":[41,268],"pyrosequencing":[42],"(PSQ)":[43],"patients":[45,56],"with":[46,58,61,133,138,231,281],"pNET":[47,59,279],"receiving":[48],"CAPTEM.":[49],"Methods:":[50],"Retrospective":[51],"and":[52,74,87,112,122,144,147,151,162,180,200,222,243],"unicentric":[53],"analysis":[54],"(p)":[57],"treated":[60,280],"CAPTEM":[62],"from":[63],"April":[64],"2008":[65],"February":[67],"2023.":[68],"MGMTdeficiency":[69],"was":[70,117,209,236],"determined":[71],"IHC":[73,130,267],"promoter":[76,123,254,269],"methylation":[77,124,255,270],"PSQ.":[79],"analyzed":[81],"patients\u2019":[82],"characteristics,":[83],"progression-free":[84],"survival":[85,89],"(PFS)":[86],"overall":[88],"(OS)":[90],"according":[91],"status.":[94],"Results:":[95],"20p":[96],"were":[97,131],"included.":[98],"Age":[99],"(median):":[100],"62":[101],"[46-77].":[102],"Males":[103],"(45%).":[104],"Tumor":[105],"grade":[106],"(G):":[107],"G1":[108],"(15%),":[109],"G2":[110,232],"(55%)":[111],"G3":[113],"(20%).":[114],"deficiency":[116,265],"detected":[118,192],"12p":[120],"(60%)":[121],"10p":[126,136],"(50%).":[127],"Results":[128],"consistent":[132],"PSQ":[134],"(50%),":[137],"mismatches":[139],"4p":[141],"(methylated":[142],"positive":[145],"IHC)":[146],"6p":[148],"(unmethylated":[149],"negative":[152,239],"IHC).":[153],"reported":[155],"higher":[157,248],"rate":[159],"MGMT-deficient":[161,168],"MGMT-methylated":[163,189],"p":[164,169,190],"(Table)":[165],".":[166],"In":[167],"we":[170,191],"observed":[171],"significantly":[172],"better":[173,193,215],"PFS":[174,194,216],"(88m":[175,195,217],"vs":[176,183,196,203,218,225,233],"11.1m;":[177],"p=0.02,":[178],"HR=0.21)":[179],"OS":[181,201,223],"(141.9m":[182],"35.8m;":[184,226],"p=0.03,":[185,220],"HR=0.20).":[186],"Also,":[187],"17.7m;":[197],"p=0.20,":[198],"HR=0.44)":[199],"(188.7m":[202,224],"141.9m;":[204],"p=0.11,":[205],"HR=0.28).":[206],"A":[207],"subanalysis":[208],"performed":[210],"based":[211],"on":[212],"G,":[213,249],"showing":[214],"6.2m;":[219],"HR=0.11)":[221],"p<0.01,":[227],"HR=0.06)":[228],"those":[230],"G3.":[234],"There":[235],"strong":[238],"correlation":[240],"between":[241],"G":[242],"PSQ;":[246],"lower":[251],"probability":[252],"r(16)=":[256],"-0.62,":[257],"p<0.01.":[258],"Conclusions:":[259],"Our":[260],"results":[261],"support":[262],"status,":[264],"PSQ,":[272],"potential":[275],"biomarker":[277],"agents.":[283],"However,":[284],"it":[285],"necessary":[287],"evaluate":[289],"prospective":[294],"studies.":[295],"[Table:":[296],"see":[297],"text]":[298]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-23T00:00:00"}